Company Filing History:
5 out of 169 
1 out of 893 
Years Active: 1999-2012
Title: Irit Alkalay: Innovator in NF-κB Modulation
Introduction
Irit Alkalay is a prominent inventor based in Jerusalem, Israel. She has made significant contributions to the field of biomedical research, particularly in the modulation of nuclear factor κB (NF-κB) activation. With a total of 5 patents to her name, her work has the potential to impact the treatment of various diseases associated with NF-κB activation.
Latest Patents
Irit Alkalay's latest patents focus on compounds and methods for modulating the activation of NF-κB. These compositions include agents that modulate the ubiquitination of phosphorylated IκBα and/or IκBβ. Such innovations may be utilized in treating diseases linked to NF-κB activation. The modulating agents she has developed include human E3 ubiquitin ligases, antibodies, and related proteins.
Career Highlights
Throughout her career, Irit has worked with notable organizations such as Signal Pharmaceuticals and Yissum Research Development Company of the Hebrew University of Jerusalem. Her expertise in the field has allowed her to contribute to groundbreaking research and development.
Collaborations
Irit has collaborated with esteemed colleagues, including Anthony M. Manning and Frank Mercurio. These partnerships have further enhanced her research and innovation capabilities.
Conclusion
Irit Alkalay is a trailblazer in the field of NF-κB modulation, with a strong portfolio of patents and collaborations. Her work continues to pave the way for advancements in medical treatments.